5 questions to test your understanding
In a clinical trial testing a new antidepressant, researchers who know which participants received the active drug (vs. placebo) conduct the follow-up interviews and rate symptom improvement. The researchers are honest and well-intentioned. Why is this design still problematic?
What was the key finding from Robert Rosenthal's classroom studies that established experimenter expectancy effects?
Experimenter bias primarily affects studies where researchers consciously and intentionally manipulate results.
A double-blind design neutralizes experimenter expectancy effects by removing the information channel through which expectations can influence researcher behavior.
Why does having good intentions not protect a researcher against experimenter bias?